Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Lisata Therapeutics (LSTA) EBT Margin (2016 - 2025)

Historic EBT Margin for Lisata Therapeutics (LSTA) over the last 11 years, with Q2 2025 value amounting to 6655.71%.

  • Lisata Therapeutics' EBT Margin changed N/A to 6655.71% in Q2 2025 from the same period last year, while for Sep 2025 it was 1794.77%, marking a year-over-year change of. This contributed to the annual value of 2078.3% for FY2024, which is N/A changed from last year.
  • Lisata Therapeutics' EBT Margin amounted to 6655.71% in Q2 2025.
  • Lisata Therapeutics' 5-year EBT Margin high stood at 461.0% for Q4 2024, and its period low was 6655.71% during Q2 2025.